
Broad-Based Technical Strength Lifts Akums Drugs & Pharmaceuticals Ltd to 52-Week High of Rs 837.9
2026-09-23 10:13:17Surging past its previous peaks, Akums Drugs & Pharmaceuticals Ltd touched a fresh 52-week high of Rs 837.9 on 23 Sep 2026, marking a remarkable 77.6% gain over the past year. This milestone reflects a powerful technical momentum that has propelled the stock well ahead of the broader market’s subdued performance.
Read full news article
Broad-Based Technical Strength Lifts Akums Drugs & Pharmaceuticals Ltd to 52-Week High of Rs 830.85
2026-09-22 09:51:35Surging past its previous peaks, Akums Drugs & Pharmaceuticals Ltd touched a fresh 52-week high of Rs 830.85 on 22 Sep 2026, marking a remarkable 73.2% gain over the past year. This milestone underscores a powerful momentum driven by a confluence of bullish technical indicators and sustained price strength.
Read full news article
Broad-Based Technical Strength Lifts Akums Drugs & Pharmaceuticals Ltd to 52-Week High of Rs 825.95
2026-09-21 09:56:25Surging past its previous peaks, Akums Drugs & Pharmaceuticals Ltd touched a fresh 52-week high of Rs 825.95 on 21 Sep 2026, marking a remarkable 72.45% gain over the past year against the Sensex’s decline of 9.56%. This milestone underscores the stock’s robust price momentum and technical alignment amid a mixed broader market backdrop.
Read full news article
Akums Drugs & Pharmaceuticals Ltd is Rated Hold
2026-09-16 10:10:51Akums Drugs & Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news article
Akums Drugs & Pharmaceuticals Ltd is Rated Hold
2026-09-05 10:10:41Akums Drugs & Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 September 2026, providing investors with an up-to-date view of its fundamentals, returns, and market performance.
Read full news article
Broad-Based Technical Strength Lifts Akums Drugs & Pharmaceuticals Ltd to 52-Week High of Rs 788.95
2026-09-01 09:53:41Surging past its previous peak, Akums Drugs & Pharmaceuticals Ltd reached a fresh 52-week high of Rs 788.95 on 1 Sep 2026, marking a remarkable 69.17% gain over the past year despite a broadly weakening Sensex. This milestone underscores the stock’s robust price momentum and technical alignment across multiple timeframes.
Read full news article
Broad-Based Technical Strength Lifts Akums Drugs & Pharmaceuticals Ltd to 52-Week High of Rs 783.9
2026-08-31 12:37:28Surging past its previous peak, Akums Drugs & Pharmaceuticals Ltd touched a new 52-week high of Rs 783.9 on 31 Aug 2026, marking a remarkable 71.65% gain over the past year. This rally stands in stark contrast to the broader market's subdued performance, with the Sensex down 3.57% over the same period.
Read full news article
Broad-Based Technical Strength Lifts Akums Drugs & Pharmaceuticals Ltd to 52-Week High of Rs 783.8
2026-08-25 13:23:18From a 52-week low of Rs 410.1 to a fresh high of Rs 783.8 on 25 Aug 2026, Akums Drugs & Pharmaceuticals Ltd has surged 56.75% over the past year, significantly outperforming the Sensex which declined by 5.48% in the same period. This milestone reflects a powerful momentum driven by a confluence of technical indicators signalling strength across multiple timeframes.
Read full news article
Akums Drugs & Pharmaceuticals Ltd is Rated Hold
2026-08-25 10:11:15Akums Drugs & Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 August 2026. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 25 August 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news articleAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
23-Sep-2026 | Source : BSEIntimation of Schedule of the Institutional Investors Meets
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
16-Sep-2026 | Source : BSEIntimation of Schedule of Investors/Analysts Meet
ESG Rating
03-Sep-2026 | Source : BSEIntimation of ESG Rating
Corporate Actions
No Upcoming Board Meetings
Akums Drugs & Pharmaceuticals Ltd has declared 50% dividend, ex-date: 03 Jul 26
No Splits history available
No Bonus history available
No Rights history available






